The Pearl clinical study will recruit 3000 patients with high-risk conditions for liver cancer with the aim of detecting liver cancer earlier as part of the Cancer Research UK-funded DeLIVER programme.
Members of the DeLIVER consortium and their collaborators have tested the performance of hepatocellular carcinoma risk prediction models in patients with cirrhosis and cured hepatitis C infection.
New research into the onset of diabetes which could go on to help in the early diagnosis of pancreatic cancer is being led by scientists at the University of Oxford.
Dr Christiana Kartsonaki and colleagues from the China Kadoorie Biobank have identified several proteins in the blood that are associated with an increased risk of pancreatic cancer.
A \u00a311 million Cancer Research UK investment has been awarded to the University of Oxford and Oxford-based NHS to catalyse the translation of its world-leading cancer research for patient benefit.
A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms. The early success of this technology makes it the first blood-based test that not only detects cancer in this population but can simultaneously identify if a cancer has spread.
Oxford University spin-out Optellum have announced their collaboration with GE Healthcare to advance lung cancer diagnosis using artificial intelligence.
Anneliese Dodds, MP for Oxford East & Chair of the Labour Party, visited the University of Oxford to learn more about the impactful cancer research happening across departments, including the work of OxCODE members.
The University of Oxford will lead a \u00a32m national cancer prevention trial in patients with Li Fraumeni Syndrome (LFS), a genetic condition that impacts 1 in 20,000 people worldwide and puts them at a 70-90% lifetime risk of cancer.
An Oxford study of cancer in children and young adults in England has found that fewer patients were diagnosed during the COVID-19 pandemic, but cancer diagnosis in children following admission to intensive care was higher.
Work by researchers at Oxford University Hospitals has highlighted how the images and accompanying data available for training artificial intelligence (AI) to spot skin cancer are insufficient and include very few images of darker skin.
Dr Weiqi Liao and Professor Julia Hippisley-Cox have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognised symptoms.
A paper led by Dr Zhiyuan Hu from Professor Ahmed Ahmed\u2019s lab has won the Columbia Hospital for Women Research Foundation\u2019s 2020-2021 prize for impact.
Dr Pui San Tan and Professor Julia Hippisley-Cox receive a Research Innovation Award from Pancreatic Cancer UK to develop a risk tool to predict pancreatic cancer in patients with diabetes.
![\"Pearl](\"https://www.oxcode.ox.ac.uk/news/first-major-uk-prospective-study-for-liver-cancer-underway/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n